Randomized trial of ingestion method of oral immunotherapy for severe egg allergic patients

Randomized trial of ingestion method of oral immunotherapy for severe egg allergic patients - Randomized trial of ingestion method of oral immunotherapy for severe egg allergic patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033346

Enrollment

Registered

2018-07-10

Start date

2018-07-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food allergy

Interventions

Oral immunotherapy by using scrambled egg Oral immunotherapy by using heated whole egg powder

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who performed oral immunotherapy by using heated whole egg powder for 12 months or more. Patients who achieved desensitization to one eight of whole egg for 3 months or more. Patients who failed oral immunotherapy of half of whole egg after 2 weeks avoidance.

Exclusion criteria

Exclusion criteria: Decision of ineligibility by a physician

Design outcomes

Primary

Measure	Time frame
Sustained unresponsiveness to half of whole egg after 12 months	—

Secondary

Measure	Time frame
Changes of egg-white and ovomucoid specific IgE, IgG, IgG4 Frequency of adverse reactions	—

Countries

Japan

Contacts

Public ContactKen-ichi Nagakura

National Hospital Organization Sagamihara National Hospital Department of pediatrics

k.nagakura@foodallergy.jp042-742-8311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026